CYP 0.00% 19.0¢ cynata therapeutics limited

Ann: Cynata announces CEO succession and Board changes, page-15

  1. 856 Posts.
    lightbulb Created with Sketch. 341
    "What CEO of an ASX company announces their "retirement" on the day they are packing up their desk and leaving the company ..... IMO it wasn't by choice"

    Finally something we can agree on. It certainly looks like he was told 'time's up, cya later.' This probably should have happened prior to the last CR, but better late than never.

    Bioscience with two representatives on the board bodes well for intrinsic value recognition. Time will tell if they can get some commercial deals done for our sideshow indications (IPF, Heart disease, CLI). Unfortunately it's unlikely the DFU trial will have results before the end of the year. It would also be reasonable to give a long overdue update on the GvHD trial progression.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $34.32M
Open High Low Value Volume
18.0¢ 19.0¢ 18.0¢ $271 1.49K

Buyers (Bids)

No. Vol. Price($)
5 101249 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 118587 1
View Market Depth
Last trade - 15.59pm 18/09/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.